IL2 and melanoma: A retrospective analysis of 631 advanced melanoma cases treated with IL-2 alone, IL-2 combined with interferon-α, or IL-2 with chemotherapy across 12 institutions suggested that IL-2 therapy may be associated with long-term survival [3].